New method to generate virus-like particles, to help with developing antibodies against Nipah
The Hindu
Institute of Advanced Virology develops safe Nipah virus-like particles for antibody studies in BSL-2 labs.
Scientists at the Institute of Advanced Virology (IAV), Thonnakkal, Thiruvananthapuram, have developed a novel way of generating non-infectious Nipah virus-like particles (VLPs) in the laboratory, which mimic the wild type Nipah virus (NiV).
Also Read: Why Nipah virus outbreaks are occurring only in Kerala
This new method offers an alternate, safe and effective platform for developing neutralising antibodies against NiV in a bio safety level-2 (BSL) laboratory. The IAV team has thus come one step closer to its mandate for developing monoclonal antibodies and anti-virals against NiV and similar pathogens.
The zoonotic virus Nipah is a highly pathogenic paramyxovirus, with a fatality rate of up to 80% in affected humans. Yet, research studies, especially virus neutralisation assays to develop specific antivirals or therapeutics against NiV, have been limited because of the extreme level of biosafety precautions required for handling this BSL-4 pathogen.
Virus neutralisation assays are critical for the development and evaluation of vaccines and immunotherapeutics, as well as for conducting basic research into the immune response and pathogenesis of NiV. These tests, which traditionally require to be done in high security labs with the infectious organism, can now be done safely in BSL-2 labs in the country using the NiV-VLPs, Director of IAV E. Sreekumar says.
The laboratory studies by the team of researchers led by Mohanan Valiyaveetil in the Department of General Virology at IAV have been detailed in the manuscript,” Highly sensitive and quantitative HiBiT-tagged Nipah virus-like particles: A platform for rapid antibody neutralisation studies,” which appeared on May 24, 2024 in the international journal Heliyon by Cell Press.
Virus-like particles (VLPs) are molecules that closely resemble viruses, but are non-infectious because they contain no viral genetic material.
Harley-Davidson X440T introduces updated rider aids, refined performance and refreshed styling, offering a modern, city-focused evolution of the successful X440.
Explore how neurotechnology, including BCIs, can transform healthcare and enhance India's capabilities in addressing neurological disorders and beyond.
Explore the fascinating physics of sound waves and their enchanting presence in nature and everyday life.
Parambriyam reopens in Anna Nagar, offering a vibrant dining experience celebrating South India's rich culinary traditions and flavors.
Scientists debate mosquito origins as fossil evidence and genomic studies clash, revealing new insights into their evolutionary timeline.
From Christmas trees fashioned out of books to real spices as ornaments
Explore how DGCA's new fatigue regulations prioritize human limits to enhance aviation safety amidst recent airline disruptions.
Experts advocate for a diversified energy strategy in India to enhance reliability and support the 500 GW non-fossil capacity target.
On December 7, 1909, Belgian-American chemist Leo Baekeland’s process patent for making Bakelite was granted, two years after he had figured it out. Bakelite is the first fully synthetic plastic and its invention marked the beginning of the Age of Plastics. A.S.Ganesh tells you more about Baekeland and his Bakelite…
Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for groundbreaking discoveries.
Explore how India’s flexible workspaces are transforming into secure, intelligent environments that safeguard data and enhance employee confidence.
Discover how collaborative policies and innovative financing can unlock affordable housing in India's urban growth landscape.
“When I turned to the mirror, it caught me unguarded. The reflection was both familiar and foreign.”